Recent Trends in Synchronous Brain Metastasis Incidence and Mortality in the United States: Ten-Year Multicenter Experience

Background: Large epidemiological studies describing the trends in incidence rates and mortality of synchronous brain metastases (SBMs) are lacking. The study aimed to provide a comprehensive understanding of the changes in the incidence and mortality of SBMs over the previous ten years. Methods: Tr...

Full description

Bibliographic Details
Main Authors: Wenqiang Che, Jie Liu, Tengyue Fu, Xiangyu Wang, Jun Lyu
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/29/11/660
_version_ 1827646860636979200
author Wenqiang Che
Jie Liu
Tengyue Fu
Xiangyu Wang
Jun Lyu
author_facet Wenqiang Che
Jie Liu
Tengyue Fu
Xiangyu Wang
Jun Lyu
author_sort Wenqiang Che
collection DOAJ
description Background: Large epidemiological studies describing the trends in incidence rates and mortality of synchronous brain metastases (SBMs) are lacking. The study aimed to provide a comprehensive understanding of the changes in the incidence and mortality of SBMs over the previous ten years. Methods: Trends in the incidence of solid malignancies outside of the CNS in patients with SBMs and incidence-based mortality rates were assessed using data from the Surveillance, Epidemiology, and End Results database. Joinpoint analyses were used to calculate annual percent changes (APCs) and 95% CIs. Results: Between 2010 and 2019, 66,655 patients, including 34,821 (52.24%) men and 31,834 (47.76%) women, were found to have SBMs, and 57,692 deaths occurred over this period. Lung cancer SBMs, melanoma SBMs, and breast cancer SBMs were ranked in the top three, having the highest age-standardized incidence rates. The incidence of SBMs decreased significantly with an APC of −0.6% from 2010 to 2019, while the APC was 1.2% for lung cancer SBMs, 2.5% for melanoma SBMs, and 0.6% for breast cancer SBMs. The SBM mortality first experienced a rapid increase (APC = 28.6%) from 2010 to 2012 and then showed a significant decline at an APC of −1.8% from 2012 to 2019. Lung cancer SBMs showed similar trends, while melanoma SBM and breast cancer SBM mortality increased continuously. Conclusions: SBMs incidence (2010–2019) and incidence-based mortality (2012–2019) declined significantly. These findings can advance our understanding of the prevalence of SBMs.
first_indexed 2024-03-09T19:09:19Z
format Article
id doaj.art-5ed70e5628054696ba3413d848f015b9
institution Directory Open Access Journal
issn 1198-0052
1718-7729
language English
last_indexed 2024-03-09T19:09:19Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Current Oncology
spelling doaj.art-5ed70e5628054696ba3413d848f015b92023-11-24T04:16:31ZengMDPI AGCurrent Oncology1198-00521718-77292022-11-0129118374838910.3390/curroncol29110660Recent Trends in Synchronous Brain Metastasis Incidence and Mortality in the United States: Ten-Year Multicenter ExperienceWenqiang Che0Jie Liu1Tengyue Fu2Xiangyu Wang3Jun Lyu4Department of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou 510630, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou 510630, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou 510630, ChinaDepartment of Neurosurgery, The First Affiliated Hospital of Jinan University, Guangzhou 510630, ChinaDepartment of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou 510630, ChinaBackground: Large epidemiological studies describing the trends in incidence rates and mortality of synchronous brain metastases (SBMs) are lacking. The study aimed to provide a comprehensive understanding of the changes in the incidence and mortality of SBMs over the previous ten years. Methods: Trends in the incidence of solid malignancies outside of the CNS in patients with SBMs and incidence-based mortality rates were assessed using data from the Surveillance, Epidemiology, and End Results database. Joinpoint analyses were used to calculate annual percent changes (APCs) and 95% CIs. Results: Between 2010 and 2019, 66,655 patients, including 34,821 (52.24%) men and 31,834 (47.76%) women, were found to have SBMs, and 57,692 deaths occurred over this period. Lung cancer SBMs, melanoma SBMs, and breast cancer SBMs were ranked in the top three, having the highest age-standardized incidence rates. The incidence of SBMs decreased significantly with an APC of −0.6% from 2010 to 2019, while the APC was 1.2% for lung cancer SBMs, 2.5% for melanoma SBMs, and 0.6% for breast cancer SBMs. The SBM mortality first experienced a rapid increase (APC = 28.6%) from 2010 to 2012 and then showed a significant decline at an APC of −1.8% from 2012 to 2019. Lung cancer SBMs showed similar trends, while melanoma SBM and breast cancer SBM mortality increased continuously. Conclusions: SBMs incidence (2010–2019) and incidence-based mortality (2012–2019) declined significantly. These findings can advance our understanding of the prevalence of SBMs.https://www.mdpi.com/1718-7729/29/11/660brain metastasestrendsincidencemortalitySEER
spellingShingle Wenqiang Che
Jie Liu
Tengyue Fu
Xiangyu Wang
Jun Lyu
Recent Trends in Synchronous Brain Metastasis Incidence and Mortality in the United States: Ten-Year Multicenter Experience
Current Oncology
brain metastases
trends
incidence
mortality
SEER
title Recent Trends in Synchronous Brain Metastasis Incidence and Mortality in the United States: Ten-Year Multicenter Experience
title_full Recent Trends in Synchronous Brain Metastasis Incidence and Mortality in the United States: Ten-Year Multicenter Experience
title_fullStr Recent Trends in Synchronous Brain Metastasis Incidence and Mortality in the United States: Ten-Year Multicenter Experience
title_full_unstemmed Recent Trends in Synchronous Brain Metastasis Incidence and Mortality in the United States: Ten-Year Multicenter Experience
title_short Recent Trends in Synchronous Brain Metastasis Incidence and Mortality in the United States: Ten-Year Multicenter Experience
title_sort recent trends in synchronous brain metastasis incidence and mortality in the united states ten year multicenter experience
topic brain metastases
trends
incidence
mortality
SEER
url https://www.mdpi.com/1718-7729/29/11/660
work_keys_str_mv AT wenqiangche recenttrendsinsynchronousbrainmetastasisincidenceandmortalityintheunitedstatestenyearmulticenterexperience
AT jieliu recenttrendsinsynchronousbrainmetastasisincidenceandmortalityintheunitedstatestenyearmulticenterexperience
AT tengyuefu recenttrendsinsynchronousbrainmetastasisincidenceandmortalityintheunitedstatestenyearmulticenterexperience
AT xiangyuwang recenttrendsinsynchronousbrainmetastasisincidenceandmortalityintheunitedstatestenyearmulticenterexperience
AT junlyu recenttrendsinsynchronousbrainmetastasisincidenceandmortalityintheunitedstatestenyearmulticenterexperience